Revision history of "Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500)" (Q80791117)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

18 August 2024

17 August 2023

12 January 2023

26 October 2022

7 August 2022

28 February 2022

4 February 2022

14 January 2022

2 November 2021

18 October 2021

4 June 2020

5 March 2020

3 January 2020